Article Details
Retrieved on: 2025-01-08 10:42:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article addresses COVID-19's impact on medication shortages in Australia, highlighting issues managed by the Therapeutic Goods Administration. It discusses challenges faced by health professionals, including disruptions in supply chains, and uses semaglutide as a key example.
Article found on: www1.racgp.org.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here